Bioanalytical Systems, Inc. (NASDAQ:BASI) saw a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 12,800 shares, a growth of 11.3% from the April 30th total of 11,500 shares. Based on an average trading volume of 17,000 shares, the days-to-cover ratio is currently 0.8 days. Currently, 0.2% of the shares of the stock are short sold.
NASDAQ BASI traded down $0.01 on Friday, reaching $1.96. The company’s stock had a trading volume of 20,387 shares, compared to its average volume of 14,068. Bioanalytical Systems has a twelve month low of $1.18 and a twelve month high of $2.17. The company has a current ratio of 0.63, a quick ratio of 0.54 and a debt-to-equity ratio of 0.91. The business has a 50 day moving average price of $1.99.
Bioanalytical Systems (NASDAQ:BASI) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($0.06) EPS for the quarter. Bioanalytical Systems had a negative net margin of 2.82% and a negative return on equity of 3.12%. The firm had revenue of $9.34 million for the quarter.
Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products.
See Also: What is a capital gains distribution?
Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.